• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

93
34
31
29
28

COUNTRY

26
11
11
7
1

CATEGORIES

  • 85
  • 77
  • 46
  • 33
  • 31
  • 23
  • 16
  • 15
  • 12
  • 11
  • 10
  • 8
  • 7
  • 7
  • 6
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

167
206
240
315

PUBLISHED

8
19
50
315

PRODUCT TYPE

213
77
22
1
1
1

Search "New Concepts in Cancer Therapeutics" returned 315 results.

Cancer Immunotherapy. Edition No. 2

There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression...

July 2013
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

July 2015
FROM
Personalized Medicine - Scientific and Commercial Aspects Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

July 2015
FROM
Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2012 Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2012 - Product Thumbnail Image

Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2012

Cancer Therapeutics CRC Pty Ltd – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2012” provides...

October 2012
FROM
RNAi - Technologies, Markets and Companies RNAi - Technologies, Markets and Companies - Product Thumbnail Image

RNAi - Technologies, Markets and Companies

RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA). Once inside the cell, this material is processed into short 21-23 nucleotide RNAs termed siRNAs that are used...

July 2015
FROM

US Companion Diagnostics Market Trends and Insights

A complete companion diagnostic market analysis must include both developers of targeted drugs and developers of companion diagnostic tests This research deliverable discusses important trends in the...

April 2014
FROM
Nanobiotechnology Applications, Markets and Companies Nanobiotechnology Applications, Markets and Companies - Product Thumbnail Image

Nanobiotechnology Applications, Markets and Companies

Nanotechnology is the creation and utilization of materials, devices, and systems through the control of matter on the nanometer-length scale (a nanometer is one billionth of a meter. Nanobiotechnology,...

July 2015
FROM

Cancer Stem Cells

Cancer Stem Cells covers a wide range of topics in cancer stem cell biology, including the functional characteristics of cancer stem cells and how they're generated, where they are localized, the means...

April 2014

Global Prostate Cancer Therapeutics Market (2010 – 2020) (Opportunity Analysis, Pipeline Assessment & Market Forecast)

Prostate cancer is the most frequently diagnosed cancer in men In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer-related mortality in men...

November 2011
FROM
Pain Therapeutics - Drugs, Markets and Companies Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic...

July 2015
FROM
Nitric Oxide - Therapeutics, Markets and Companies Nitric Oxide - Therapeutics, Markets and Companies - Product Thumbnail Image

Nitric Oxide - Therapeutics, Markets and Companies

This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric oxide-based...

July 2015
FROM

Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria

This report covers evolutionary growth of antibiotic resistant bacteria with a focus in research aspects, commercial aspects, market aspects, and trends in antibiotic resistance. Antibiotic resistance...

June 2014
FROM

Multitargeted Therapies: Promiscuous Drugs and Combination Therapies

Suites of drugs have been developed that can be used in combination to treat complex diseases that have multiple causes involving multiple targets. In addition, it has been found that many successful...

June 2011
FROM

Gene Therapy of Cancer. Edition No. 3

Gene therapy as a treatment for cancer is at a critical point in its evolution. Exciting new developments in gene targeting and vector technology, coupled with results from the first generation of preclinical...

October 2013
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities - Product Thumbnail Image

Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities

This cutting edge & insightful report can be used to interpret & assess the potential of RNAi-based medicines It provides opinions & market projections to: - assess the commercial potential of RNAi-based...

July 2009

Bispecific Antibodies: Clinical Trial Tracker

Bispecific antibodies (bsAbs) are artificial antibodies created by joining together two monoclonal antibodies (or parts) that target different epitopes The resulting antibody has binding affinities...

February 2014
FROM

Epigenetic Cancer Therapy

Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also...

July 2015

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

November 2014
FROM

Immune Checkpoint Inhibitors Market, 2014 - 2024

Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues to...

November 2014
FROM

Gene Therapy - Global Strategic Business Report

This report analyzes the Global market for Gene Therapy in US$ Million Annual estimates and forecasts are provided for the period 2009 through 2017 The report profiles 98 companies including many key...

February 2012
FROM
Loading Indicator

Our Clients

Innocent Drinks Ltd. Groupe Danone Cisco Systems, Inc. The World Bank Group Swarovski AG Owens Corning Corporation Swiss Reinsurance Company Ltd.